[ adverts ]
| 13/05/2008 |
| Daily Telegraph |
| By: Roger Highfield |
| Viagra may beat MD side effects, say doctors |
| Viagra may be able to reduce the damage to heart muscle caused by muscular dystrophy, researchers said yesterday. Canadian researchers, reporting in the Proceedings of the National Academy of Sciences, gave mice a dose of comparable to that taken for erectile dysfunction in men, and found that the drug significantly reduced the levels of damage to contracting heart muscle cells. |
|
[ linebreak ]
|
| 13/05/2008 |
| Daily Telegraph |
| By: Kate Devlin |
| Women 'cut cancer risk with exercise' |
| Taking regular exercise can reduce the risk of developing breast cancer by a quarter, a review suggests today. A study published online by the Journal of Sports Medicine looked at more that 60 studies and found that compared with those who took little or no exercise, women who worked out regularly were 25 to 30 per cent less likely to contract the disease. |
|
[ linebreak ]
|
| 13/05/2008 |
| Daily Telegraph |
| By: Daily Telegraph Reporter |
| Breast is best to fight rheumatoid arthritis |
| Women can halve their chance of rheumatoid arthritis by breast-feeding their children for more than a year, researchers said yesterday. Swedish scientists compared 136 women with rheumatoid arthritis with 544 of a similar age who were free from the disease and found that those who breast-fed for 13 months or more were 54 per cent less likely to develop the condition as women who had not. Even women who breastfed for between one and 12 months were 26 per cent less likely to suffer the disease. |
|
[ linebreak ]
|
| 13/05/2008 |
| Daily Telegraph |
| By: Rebecca Smith |
| Desk-bound workers at double DVT risk |
| Office workers who sit at a desk for eight hours a day and spend more than three hours without stretching double their risk of developing deep vein thrombosis (DVT), researchers in Southampton and New Zealand have warned. |
|
[ linebreak ]
|
| 13/05/2008 |
| The Guardian |
| By: Staff |
| Study calls for cut in price of cervical cancer drug |
| A study presented yesterday at a conference of public health institutions has called for the cost of the new cervical cancer vaccine to be cut if many thousands of women's lives are to be saved in the developing world, where the disease takes the greatest toll. The cost in the US of the vaccines, which are manufactured by Merck and British drug giant GlaxoSmithKline, is $360 (about £180) a treatment. |
|
[ linebreak ]
|
| 13/05/2008 |
| Financial Times |
| By: Nicholas Timmins |
| Reform of care in old age to gain priority |
| A big public consultation about how social care should be funded was launched by Gordon Brown yesterday - though there is no chance of substantive change before the next general election. Niall Dickson, chief executive of the King's Fund health think-tank that helped put the issue higher on the agenda said a frank and open debate was needed for fundamental reform. |
|
[ linebreak ]
|
| [ End of selection ] |
| Top of the page |